CyDex Pharmaceuticals, Inc. company was founded in 1993 and is based in Lenexa, Kansas. CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company’s products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphenytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for allergic rhinitis. In addition, the company out license its technology to third parties for use in the development of their products. CyDex Pharmaceuticals, Inc. was formerly known as CyDex, Inc. and it changed its name in November 2007.

GSK Consumer Healthcare, a unit of druggernaut GlaxoSmithKline, makes and sells a wide range of over-the-counter drugs, oral care products, and nutritionals. Brands and products range from oral care (Aquafresh toothpaste) to dermatology (Zovirax cold sore medication), with all kinds of analgesics (Panadol), gastrointestinal remedies (Tums), and smoking-cessation products (Nicoderm) in between. GSK Consumer Healthcare also makes a variety of vitamins and natural remedies, as well as the weight loss product alli.

DUSA Pharmaceuticals, Inc. was founded in 1991 and is based in Wilmington, Massachusetts. DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The BLU-U is used without Levulan to treat moderate inflammatory acne vulgaris and general dermatological conditions. The company is also developing non-PDT drug products, including Nicomide, Nicomide-T, AVAR products, ClindaReach, Meted, and Psoriacap products.

Quest PharmaTech aims to shed some light on dermatology and cancer treatments. Working with Hypocrellin, a photosensitive compound isolated from pigments found in fungi on bamboo, the company has developed its SonoLight Technology. The compound is relatively harmless until activated by light or ultrasound, whereupon it begins to destroy tissue. The company's pipeline of drug candidates include treatments to facilitate laser hair removal, address acne, and improve prostate cancer therapies. The company has sold off several earlier products to focus on its current pipeline and continues to consider strategic alternatives to facilitate its growth.

BioFocus DPI takes the guesswork out of your drug discovery. The UK-based company specializes in pre-clinical drug discovery services, assay development and screening, and compound management (including storage and delivery). The company's major clients include Pfizer, Procter & Gamble, and GlaxoSmithKline. BioFocus was founded by a group of Wellcome scientists in 1997, and about a decade later was acquired by Galapagos. It now operates as that company's services division. Formerly known as BioFocus, the firm added DPI to its name after Galapagos acquired the drug discovery business of Discovery Partners International and merged it with existing BioFocus operations.

Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and changed its name to Fluidigm Corporation in June 2001. The company is based in San Francisco, California. Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis.

Solvay Pharmaceuticals is out to solve the medical maladies of the world. Part of Solvay SA's pharmaceuticals division, the US-based company develops, produces, and markets therapies for cardiovascular, gastroenterological, and neurological disorders. Solvay Pharmaceuticals also makes and markets flu vaccines and products for specialized markets such as women's and men's health. Its marketed products include AndroGel (testosterone replacement gel), Marinol (appetite stimulator and antiemetic), and ACEON (an antihypertension drug). Abbott Laboratories has agreed to acquire the Solvay Pharmaceuticals organization. Solvay Pharmaceuticals is led by CEO Stephen Hill.

Watson Pharmaceuticals, Inc. was founded in 1983 and is based in Corona, California. Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2008, the Company marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its generic and brand divisions, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its distribution division. The Company’s operations are based predominantly in the United States and India, with its key commercial market being the United States. In December 2009, the Company completed the acquisition of Arrow Group. In January 2010, the Company completed the acquisition of Eden Biopharm Group Limited.

China-Biotics, Inc. is engaged in the research, development, production, marketing and distribution of probiotics products, which are products that contain live microbial food supplements, which beneficially affect the host by improving its intestinal microbial balance. The Company manufactures and sells several health supplements under the Shining brand in the Shanghai area. It has four major products: Shining Essence, Shining Signal, Shining Golden Shield and Shining Energy. Shining Essence is composed of lactobacillus acidophilus and bifidobacterium bifidum, which is focused on balancing the microecology of the digestive system. Shining Signal is composed of monascus rice and lactobacillus acidophilus, focused on reducing high-blood pressure, high-blood sugar level and hyperlipidemia. Shining Golden Shield is composed of bifidobacterium adolescentis and lentinusedodes. Shining Energy is composed of Vitamin C, L. Arginine, and other amino acids.

Nippon Kayaku Co., Ltd. company is divided into three primary business lines: functional chemicals, pharmaceuticals, and automotive safety parts (airbags, ignition parts). It also manufactures pesticides and herbicides. Its pharmaceuticals segment is focused on producing anti-cancer drugs and immunosuppressants as well as cardiovascular and neurological drugs (brand name and generics). Other products in its divisions include dyes, inflators for automobile airbags, industrial explosives, epoxy resins, and agricultural chemicals. Nippon Kayaku has offices, manufacturing plants, and laboratories in Japan, as well as operations in China, Germany, Taiwan, and the US.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.